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Purpose: The use of bacteriophages represents a valid alternative to conventional antimicrobial 
treatments, overcoming the widespread bacterial antibiotic resistance phenomenon. In this work, 
we evaluated whether biomimetic hydroxyapatite (HA) nanocrystals are able to enhance some 
properties of bacteriophages. The final goal of this study was to demonstrate that biomimetic 
HA nanocrystals can be used for bacteriophage delivery in the context of bacterial infections, 
and contribute – at the same time – to enhance some of the biological properties of the same 
bacteriophages such as stability, preservation, antimicrobial activity, and so on.
Materials and methods: Phage isolation and characterization were carried out by using 
Mitomycin C and following double-layer agar technique. The biomimetic HA water suspension 
was synthesized in order to obtain nanocrystals with plate-like morphology and nanometric 
dimensions. The interaction of phages with the HA was investigated by dynamic light scat-
tering and Zeta potential analyses. The cytotoxicity and intracellular killing activities of the 
phage–HA complex were evaluated in human hepatocellular carcinoma HepG2 cells. The 
bacterial inhibition capacity of the complex was assessed on chicken minced meat samples 
infected with Salmonella Rissen.
Results: Our data highlighted that the biomimetic HA nanocrystal–bacteriophage complex 
was more stable and more effective than phages alone in all tested experimental conditions.
Conclusion: Our results evidenced the important contribution of biomimetic HA nanocrystals: 
they act as an excellent carrier for bacteriophage delivery and enhance its biological character-
istics. This study confirmed the significant role of the mineral HA when it is complexed with 
biological entities like bacteriophages, as it has been shown for molecules such as lactoferrin.
Keywords: biomimetic hydroxyapatite nanocrystals, Salmonella Rissen, bacteriophages, 
antibiotic resistance
Introduction
Inappropriate abuse of antibiotics has led to the development of drug-resistant 
microorganisms.1 Antibiotic resistance is a constantly evolving phenomenon and 
represents a serious problem with high death toll and a substantial economic impact 
worldwide; it complicates patient management and treatment strategy and prolongs 
hospital stays. In Europe antibiotic-resistant bacteria infect 4 million people every 
year.2,3 Therefore, therapies that can serve as an alternative to antibiotics need to 
be developed.
A valid and alternative approach to solve the widespread phenomenon of “antibi-
otic resistance” of different pathogens such as Salmonella,4 Staphylococcus aureus,5 
Escherichia coli,6 and Streptococcus7 – in addition to well-known antimicrobial peptides8 – 
is the use of bacteriophages or phages. Bacteriophages are the most abundant viruses 
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found in the biosphere;9,10 they grow quickly and exponen-
tially, and they are efficacy since the fist interaction with 
bacteria.11 At the same time, phages have some disadvan-
tages such as low stability over time and low resistance (or 
short half-life) in acidic environments such as that of the 
stomach.12,13
These limitations could be overcome by stabilizing the 
phages by combining them with nanoparticles of different 
materials such as carbon, silica, metal oxide, graphene, and 
hydroxyapatite (HA). HA, in particular, has been frequently 
used in several studies to stabilize, protect, and deliver mol-
ecules or radionuclides.14–22
HA represents the major components of bone, tooth, and 
cartilaginous tissues. It possesses several properties such as 
biocompatibility, biomimetic dimensions, osteoconductiv-
ity, and degradability, which make it suitable for several 
applications16,23 when combined with different biological 
molecules.19 Indeed, HA nanocrystals have been success-
fully employed to build bone scaffolds and implant coating 
materials and vehicles for drug targeting.24–29 Furthermore, 
HA nanocrystals have low toxicity and remarkable stability, 
as reported in our previous studies.30
In industrialized countries, infections acquired by food 
and water represent a big concern for public health, and 
about 50% of foodborne infections in humans are caused by 
Salmonella spp.31 Despite control measures and monitoring 
carried out by the healthcare authorities, cases of Salmonella 
contaminations are still very frequent.32
Salmonella serovars such as Enteritidis and Typhimurium 
are accountable for most of the salmonellosis cases.33 In recent 
years, infections by other serovars such as Kentucky and 
Rissen became more frequent; the latter Salmonella strain, 
especially, has been isolated from pork and chicken products 
and in human and swineherds gastrointestinal tract.34,35
Based on these considerations, we decided to investigate 
whether the biomimetic HA nanocrystals – which mimick 
the natural bone mineral – could interact with Salmonella 
bacteriophages and whether the newly developed complex 
could control Salmonella bacterial infection.
Materials and methods
Bacteria
All the Salmonella spp. strains used in this study were 
provided by the Istituto Zooprofilattico Sperimentale Del 
Mezzogiorno (Portici, Naples, Italy). Among these, S. Rissen 
was selected as reference strain for bacteriophage (phage) 
isolation.
Phage isolation
Phage (SR φ1) from S. Rissen was isolated as described by 
Capparelli et al.36 Briefly, S. Rissen was grown in 5 mL of 
Luria Bertani broth (LB; Sigma-Aldrich Co., St Louis, MO, 
USA) and, when the culture reached the exponential growth 
phase, Mitomycin C (1 µg/mL) was added. Then, the suspen-
sion was incubated at 37°C for 30 minutes. After incubation, 
it was centrifuged twice at 5,000 rpm for 10 minutes; each 
time the supernatant was discarded and the pellet resuspended 
in 5 mL of LB in order to remove any residue of Mitomycin 
C. Later, the suspension was incubated at 37°C for 4 hours. 
Then another centrifugation step was carried out but this 
time, the supernatant – containing bacteriophages – was col-
lected, filtered through a 0.22 µm membrane, and screened 
for the presence of phages using the double-layer agar (DLA) 
method. The last step included a lower nutrient agar layer 
and an upper soft agar layer (4 mL of 0.7% bacteriological 
agar [Sigma-Aldrich Co.] mixed with 107 colony forming 
unit [CFU]/mL of bacterial strain used for phage isolation 
and previously filtered bacteriophage solution). After over-
night incubation at 37°C, the plates were observed for the 
presence of clear zone (plaque formation) over the surface 
of the double agar plate. The phages isolated were stored 
at -20°C in buffer SM.37 However, the pellet was streaked 
onto Salmonella Chromogenic Agar Base (CM1007, Oxoid; 
Thermo Fisher Scientific, Waltham, MA, USA) to confirm 
the presence of Salmonella spp. bacteria.
The titer of phage, expressed as plaque forming units 
(PFUs), was evaluated by using the DLA technique as 
reported by Sambrook et al.38
Phage host range
Host range of phages was evaluated against 14 different 
Salmonella strains by the overlay method.39 Briefly, the test 
consisted of spotting 100 µL of SR φ1 on the surface of a 
double agar layer as reported above.
Multiplicity of infection (MOI) of phage
MOI is the ratio of virus particles to host cells.40 To establish 
the best MOI, S. Rissen strain was grown in LB at 37°C till 
104 CFU/mL. Later, 100 µL of bacterial suspension was 
treated with 100 µL of SR φ1 at different ratios, ranging from 
10-3 to 103 PFU/CFU, in a 96-well microplate. Positive and 
negative controls were represented by a mixture contain-
ing 100 µL of S. Rissen (104 CFU/mL) plus 100 µL of SM 
buffer or 100 µL of LB broth plus 100 µL of SM buffer, 
respectively. After 16–18 hours of incubation at 37°C, the 
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optical density was measured at OD 600 nm to determine 
the optimal MOI. This last parameter shows that the lower 
phage titer is able to kill the majority of the bacteria, and it 
was used for all the subsequent experiments.
One-step growth curve
The “burst size” and phage life cycle were evaluated 
by the one-step growth assay. The culture of S. Rissen 
(108 CFU/mL), in exponential growth phase, was infected 
with phage according to the optimal MOI (previously 
selected). The mixture was incubated at 37°C for 5 minutes 
to favor phage adsorption, and later, it was serially diluted up 
to 10-4 in 20 mL of LB. The above mixture was incubated at 
37°C for 90 minutes, and 100 µL of sample was taken every 
5 minutes and plated, during the whole incubation period. 
Latent period was the interval between the beginning of the 
adsorption (not including 5 minutes pre-incubation) and the 
onset of the first burst (corresponding to the initial rise in 
phage titer). Burst size was the ratio between the final count 
of released phage particles and the initial amount of infected 
bacterial cells.
electron microscopic analysis
SR φ1 (108 PFU/mL) was purified by CsCl density gradient 
ultracentrifugation and dialyzed against SM buffer overnight 
at 4°C.41 Phage particles were negatively stained with 2% 
of phosphotungstic acid (pH 7.2) for 20 minutes. Later, 
phages were observed by using a Philips EM 300 electron 
microscope.
Phage phylogenetic analysis
Phylogenetic analysis was performed using the maximum 
likelihood method.42 Data alignment was carried out with 
Blosum 65 (gap open penalty =11; gap extension penalty =3) 
and tree was built by using Jukes-Cantor and UPGMA 
models.
Phage genome sequencing, assembly, and 
annotation
Genomic DNA was quantified using the Qubit dsDNA BR 
Assay Kit (Thermo Fisher Scientific); DNA purity was 
assessed with a Nanodrop (Thermo Fisher Scientific), and 
DNA size was determined with a 2200 Tape Station Instru-
ment (Agilent Technologies, Santa Clara, CA, USA). Illu-
mina libraries were produced starting from 1 µg of genomic 
DNA, which was sheared using the Covaris S220 instrument 
(Covaris Inc. Woburn, MA, USA) and the TruSeq DNA 
Sample Prep Kit (Illumina, San Diego, CA, USA) following 
the manufacturer’s guidelines. Sequencing was performed 
on a NextSeq500 instrument with the 150-nt paired-end 
protocol (Illumina) according to the manufacturer’s guide-
lines. Illumina reads underwent quality filtering and trim-
ming using Sickle and were quality corrected with Bayes 
Hammer before being assembled de novo. Genomes were 
assembled de novo from Illumina reads using SPAdes 2.9.0 
with multiple k-mer combinations. The resultant contigs were 
scaffolded using SSPACE 3.0. Five micrograms of high-
molecular-weight genomic DNA (peak .60 kb) was used to 
prepare ~20 kb-insert single-molecule real-time (SMRT)-bell 
libraries according to the manufacturer’s guidelines (Pacific 
Biosciences, Menlo Park, CA, USA). The library templates 
were sequenced using the SMRT sequencing technology 
on a PacBio RSII sequencer (Pacific Biosciences) at Mac-
rogen, Inc (Korea). PacBio subreads were extracted using 
Bash5tools (version 0.8.0), filtrated, and assembled de novo 
using Falcon-Integrate with the suggested settings for bacte-
rial genome. The assembled genome sequence was polished 
by Quiver v 0.9.2, and gene annotation was performed using 
RAST web service (http://rast.nmpdr.org/).43
Biomimetic ha nanocrystal synthesis and 
characterization
Biomimetic HA nanocrystals were produced as described by 
Nocerino et al.44 Briefly, HA nanocrystals were precipitated 
from an aqueous solution of (CH
3
COO)
2
Ca (75 mM) by slow 
addition (one drop per second) of an aqueous solution of 
H
3
PO
4
 (50 mM), keeping the pH constant at 10 (by the addition 
of (NH
4
)OH solution). The synthesis was performed at room 
temperature. After this last process, the suspension of HA was 
washed with distilled water in order to remove ammonium 
ions and favor the interaction between nanocrystals.
Transmission electron microscopy (TEM) investigation 
was carried out using a 1200 EX microscope, linked to X-ray 
analysis detectors and a 3010 UHR operating at 300 kV (JEOL 
Ltd, Tokyo, Japan). Few droplets of the samples (in ultrapure 
water) were deposited on perforated carbon foils supported 
on conventional copper microgrids. The surface area was 
determined using a Sorpty 1750 instrument (Carlo Erba 
Reagents S.r.l., Milan, Italy) using N
2
 absorption at 77 K.45
synthesis of complex ha–sr φ1
The HA–SR φ1 complex was prepared by mixing 10 mL of 
HA (100 mg/mL) with 10 mL of SR φ1 (107 PFU/mL) under 
stirring wad. The suspension was stable, and no precipitation 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
18
5.
50
.2
50
.1
92
 o
n 
28
-M
ar
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2019:14submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2222
Fulgione et al
phenomena were observed during the synthesis process. 
Later, aliquots of 1 mL of the mixture were incubated – 
under shaking – at room temperature for the following time 
intervals: 30, 90, 180, and 300 minutes and 24 hours. After 
proper incubation, the sample was centrifuged, and the pel-
let was suspended in SM buffer. The concentration of the 
active phage particles was evaluated by the DLA method. 
After overnight incubation, the optimal incubation time was 
selected according to the results. Next, other tests were car-
ried out by maintaining constant concentration of the HA 
but increasing the bacteriophage titer. The results showed 
that, by increasing the phage titer, the concentration of the 
active phage particles estimated by the DLA method, after 
the optimal time of incubation, remained constant at 107 PFU/
mL (the titer used for the above complex synthesis) (data not 
shown). Based on these data, we evidenced that the maximum 
loading capacity of the HA used for this study was 107 PFU/
mL of bacteriophages.
complex ha–sr φ1 characterization
Zeta potential, dynamic light scattering (Dls) 
analysis, and ph stability
SR φ1, HA–SR φ1, and HA were analyzed for the measure-
ment of zeta potential and DLS in appropriate disposable 
folded capillary cells (DTS1070; Malvern Instruments, 
Malvern, UK) using a Zetasizer Nano ZS (Malvern Instru-
ments). For the DLS analysis, the instrument was, in addi-
tion, equipped with a 633 nm He–Ne laser and an avalanche 
photodiode detector placed at a detection angle of 173°. Each 
analysis was carried out in triplicate for three independent 
experiments. The analysis temperature was 25°C and about 
1 mL of sample (at pH value of 7) was used for the test. The 
results were examined, and, for each sample, the zeta poten-
tial average and DLS measurement value were determined.
To estimate the stability of SR φ1 and HA–SR φ1 over 
time, the titer of phage – or mixed with HA – was evaluated 
for 2 successive months, at weekly intervals. During this 
time, the samples were stored at +4°C.46
In addition, the effects of an acid or alkaline pH, on SR φ1 
or HA–SR φ1 complex, were evaluated by mimicking differ-
ent pH conditions (ranging from 2 to 10). Briefly, the phage 
suspensions were incubated at 37°C for 1 hour in buffer SM 
at the following pH values: 2, 4, 7, and 10. After incubation, 
the phage titer was estimated by the DLA method as reported 
by Jun et al.47 Each assay was performed in triplicate.
X-ray analysis
X-ray powder diffraction (XPD) patterns were obtained at 
room temperature by using a Rigaku RINT2500 rotating 
anode laboratory diffractometer (50 kV, 200 mA) equipped 
with the silicon strip Rigaku D/teX Ultra detector. An 
asymmetric Johansson Ge (111) crystal was used to select 
the monochromatic Cu Kα1 radiation (λ=1.54056 Å). The 
measurements were carried out in transmission geometry by 
introducing the samples in a Lindemann glass capillary of 
0.3 mm diameter. The XPD patterns were first indexed by 
the program QUALX48 by matching the XPD patterns with 
the ICSD database. They were further analyzed by using a 
whole-profile Rietveld-based fitting program49 to determine 
the crystalline domain size as follows:
1. The instrumental resolution function (IRF) was evalu-
ated by fitting the XPD pattern of a LaB6 NIST standard 
recorded under the same experimental conditions as those 
used for measuring the samples. The IRF data file was 
provided separately to the program in order to allow 
subsequent refinement of the diffraction patterns of the 
samples.
2. The crystal structure of the samples, once determined, was 
input into the program and refined. The inhomogeneous 
peak broadening of the diffraction peaks was described by 
a phenomenological model based on a modified Scherrer 
formula: 
 
β
λ
θ
λ
θ
θ
h,k,l h 
= =
cos cos 
( , a y
imp impimp h h∑ Φ )
where β
h,k,l
 represent the size contribution to the integral width 
of the (h,k,l) reflection and are real spherical harmonics. After 
refinement of the α
imp
 coefficients, the program calculates the 
apparent size of the crystal domains along each reciprocal 
lattice vector (h,k,l) direction.
cytotoxicity trials
MTT assay
Human hepatocellular carcinoma HepG2 (HB-8065; American 
Type Culture Collection [ATCC], Manassas, VA, USA) cells 
were grown in minimal essential media (MEM) plus 10% 
FBS, 2 mM glutamine, 1% nonessential amino acids (NEAA), 
100 U/mL penicillin, and 100 µg/mL streptomycin (all from 
Thermo Fisher Scientific). Cells (200 µL at 30,000 cells/well) 
were placed in a 96-well plate and were treated with SR φ1 
(107 PFU/mL), HA–SR φ1 (100 mg/mL plus 107 PFU/mL), 
or HA (100 mg/mL) for 24, 48, and 72 hours, respectively.
The positive and negative controls contained 10% 
DMSO or PBS, respectively. All the conditions tested were 
performed in triplicate. An aliquot of 20 µL of MTT dis-
solved in PBS at a concentration of 5 mg/mL was added to 
each well. After 2 hours, the supernatant was discarded and 
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150 µL of isopropanol was added. The plate was incubated 
at 37°C for 30 minutes and then, the optical density was 
measured at 560 nm.
lactate dehydrogenase (lDh) assay
An LDH assay was performed using a CytoTox 96 Non-
Radio cytotoxicity assay kit (Promega Corporation, Fitch-
burg, WI, USA) at 24, 48, and 72 hours according to the 
manufacturer’s protocol. The LDH levels were evaluated 
for all the conditions tested for the MTT assay.
Internalization of fluorescent HA–SR φ1
In order to evaluate the internalization of the complex, HA 
nanoparticles were labeled by fluorescein isothiocyanate 
(FITC). Briefly, HA (100 mg/mL) was mixed with 20 mL of 
3-aminopropyltriethoxysilane (Sigma-Aldrich Co.) in 100 mL 
of anhydrous ethanol and stirred at 74°C for 3 hours. Later, 
fluorescein (6 µg/mL; Sigma-Aldrich Co.) was added and 
continued to react at 74°C for about 20 hours in the dark. The 
mixture was centrifuged at 5,000 rpm for 1 minute and the pel-
let was rinsed three times with anhydrous ethanol and deion-
ized water, and later suspended in SM buffer.50 Subsequently, 
SR φ1 (107 PFU/mL) was added to the HA previously labeled. 
An aliquot of 10 µL of the complex HA–SR φ1 at different 
dilutions (1:1,000, 1:100, and 1:10) was added to HepG2 cells 
(1.0×105 per well) for 24 hours. The control cells were treated 
with 10 µL of SM buffer. After treatment, the medium was 
discarded, and cells were rinsed twice with PBS and fixed in 
4% paraformaldehyde for 10 minutes at room temperature. 
DAPI was used to counterstain nuclei. Slices were observed 
using a Zeiss LSM 710 Confocal Laser Scanning Microscope 
(Carl Zeiss MicroImaging GmbH). Samples were vertically 
scanned with a 63× or 40× (1.40 NA) Plan-Apochromat oil-
immersion objective. Images were obtained with Zeiss ZEN 
Confocal Software (Carl Zeiss MicroImaging GmbH).
Intracellular killing activity
HepG2 cells were placed in a 24-well plate (0.2×106 cells/
well), incubated overnight (37°C, 5% CO
2
) in MEM 
supplemented with 10% FBS (Thermo Fisher Scientific). 
The experiment was carried out in two different ways in 
order to evaluate different types of antimicrobial activity 
of the complex according to different infection processes. 
First, the cells were infected with S. Rissen (108 CFU/mL) 
for 1 hour. The medium was discarded, and the cells were 
washed with PBS (three times) and incubated in MEM plus 
10% FBS and gentamicin (12.5 µg/mL)36 at 37°C in 5% 
CO
2
 for 3 hours. Later, the cells were treated with SR φ1 
(107 PFU/mL), HA–SR φ1 (100 mg/mL plus 107 PFU/mL), 
or HA (100 mg/mL) for 24 hours as reported by McLaughlin 
et al51 and Withanage et al.52
In the second infection process, the cells were infected 
with S. Rissen (108 CFU/mL) and simultaneously treated 
with SR φ1 (107 PFU/mL), HA–SR φ1 (100 mg/mL plus 
107 PFU/mL), or HA (100 mg/mL) for 1 hour. The cells 
were then treated with gentamicin as described above. After 
3 hours of incubation at 37°C in 5% CO
2
, the medium was 
discarded, and the cells were incubated in MEM containing 
10% FBS for 24 hours.
The cells of both experiments were lysed with Tween 20 
(0.05%) and incubated at 37°C in 5% CO
2
 for 4 hours, and 
each lysate was then serially diluted in PBS and plated on 
XLT4 (Sigma-Aldrich Co.). The plates were incubated at 
37°C overnight and evaluated for the presence of bacteria.
Both the above experiments were carried out using 
mouse macrophage cell line J774A.1 (TIB-67; ATCC) 
instead of HepG2 cells. J774A.1 cells were grown in DMEM 
supplemented with 10% FBS, 2 mM glutamine, 1% NEAA, 
100 U/mL penicillin, and 100 µg/mL streptomycin (all from 
Thermo Fisher Scientific). Cells were maintained in a humidi-
fied, 37°C, 5% CO
2
 incubator.
Bacterial reduction assay on chicken 
minced meat
S. Rissen was processed as reported by Sukumaran et al.53 
For the test, 250 g of chicken minced meat was divided into 
five equal parts. Four sections were infected with S. Rissen 
(103 CFU/mL) and incubated at room temperature accord-
ing to ISO 16140-2: 2016;54 while the last one was treated 
only with PBS (negative control). After 30 minutes, three of 
the four infected parts were treated respectively with SR φ1 
(108 PFU/mL), HA–SR φ1 (100 mg/mL plus 108 PFU/mL), or 
HA (100 mg/mL). All samples were stored at 4°C for 7 days 
and tested for the presence of the bacteria every 24 hours. 
In particular, at each time point, 5 g of meat was taken from 
each sample and homogenized in 45 mL of 0.1% buffered 
peptone water (AES Laboratoire Groupe, France) at 200 rpm 
for 1 minute, using the Stomacher 400 Circulator (Seward 
Ltd, Bohemia, NY, USA). Subsequently, 100 µL of sample 
was plated on XLT4 agar and incubated at 37°C for 24 hours. 
The efficacy of each treatment was evaluated by counting the 
CFU formed on the plate after the incubation time.
Results
Phage isolation and characterization
Phage excision from S. Rissen was induced by Mitomycin 
C procedure.36,55 The SR φ1 host range was tested against 14 
Salmonella strains, each belonging to a different serovar, and 
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it was active against 11 out of 14 selected strains (Table 1). 
The MOI test allowed us to select the value of 0.1 as optimal 
MOI (Figure S1). This value has been used for all the later 
experiments. The one-step growth analysis highlighted that 
the latent period of SR φ1 was 60 minutes (Figure S2) and 
that its burst size was 54 PFU/cell.
TEM analysis of SR φ1 allowed us to classify the phage as 
a member of the Podoviridae family, according to a previous 
publication.10 In particular, TEM analysis revealed that the 
tail length and head diameter were 16±2.0 nm (mean ± SD) 
and 57±1.0 nm (mean ± SD), respectively; and the total length 
was 73±2.0 nm (mean ± SD) (Figure 1).
comparative genomic analysis of phage
DNA sequencing yielded a total of 2,199,543 reads (660 Mb) 
and an average coverage of 13,200×. Phage SR φ1 genome 
consists of 51,738 bp with a G+C content of 48.4%. The 
genomic sequence of SR φ1 described in this study has 
been deposited in the GenBank database (accession number: 
KY709687). Open reading frames (ORFs) with a length of 
at least 38 amino acids were selected. A total of 622 ORFs 
were predicted to be present within the genome. However, 
only 87 ORFs (13.98%) were predicted to be functional 
based on gene predictions and annotation of the genome 
(Figure 2). Concrete gene information such as positions, 
directions, sizes, and putative functions of SR φ1 coding 
DNA sequences (CDSs) are shown in Table S1. The genome 
contains 87 predicted CDSs, of which 70 matched with 
already identified phage genes. Identified genes included 
30 genes affecting bacteriophage physiology, 12 phage 
structures, 10 DNA replication, and three bacterial lysis. The 
remaining 32 CDSs encoded hypothetical proteins. Phage SR 
φ1-predicted genome did not show genes coding for toxins, 
antibiotic resistance, or Salmonella virulence.
To gain an insight into the characteristics of the phage SR 
φ1 genome, we performed a phylogenetic analysis, compar-
ing its genome to the predicted genomes of other 37 fully 
sequenced phages. The phylogenetic analysis confirmed that 
phage φ1 is a Podoviridae, specifically showing 19 homologous 
genes with PHAGE_Salmon_SPN9CC (NC017985) (Figure 3).
Biomimetic ha nanocrystal 
characterization
The biomimetic HA nanocrystals used in this study had a 
composition very close to that of the human body.56
The TEM analysis revealed the length of HA nanocrystals 
(~30–40 nm) and its plate-like morphology (Figure S3). The 
high reactivity of HA is ascribed to its amorphous surface16 
and to its high surface area of about 110 m2/g, which is only 
slightly lower than that of biological nanocrystals (120 m2/g).30
Moreover, the degree of crystallinity and the presence of 
carbonate ions in the structure of biomimetic HA (data not 
shown) clearly confirm that the HA selected for this study 
is – structurally – very similar to that of the bone, not only 
in the size of the nanocrystals but also in ionic substitution.
Preparation and characterization of the 
complex (ha–sr φ1)
The interaction of SR φ1 with HA, carried out as reported 
in Patent IT102017000050733,57 was evaluated at different 
Table 1 Phage host range against different Salmonella strains
Bacteria Lytic activity
S. Livingstone +
S. Infantis +
S. Potsdam +
S. Thompson -
S. Mbandaka +
S. Winston +
S. Montevideo -
S. Virchow +
S. Ohio +
S. Jerusalem -
S. Inganda +
S. Wil +
S. Typhimurium +
S. Enteritidis +
Notes: + indicates lysis after infection with sr φ1; - indicates lack of lysis after 
infection with sr φ1.
??????
Figure 1 electron microscopic analysis of phage. sr φ1 observed with a TeM 
analysis. scale bar, 100 nm.
Abbreviation: TeM, transmission electron microscopy.
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Figure 2 Functional genome map of phage sr φ1.
Notes: hypothetical functions of encoded proteins were determined by comparison of amino acid sequences to the non-redundant databank using BlasTP. annotation was 
verified using PHAST, a web server designed to rapidly and accurately identify, annotate, and graphically display prophage sequences within bacterial genomes or plasmids. 
The + and - stranded OrFs were colored in yellow.
Abbreviations: BlasTP, Basic local alignment search Tool Protein; OrFs, open reading frames; PhasT, Phage search Tool.
incubation time intervals. The results showed that SR φ1 has 
interacted with HA already after 30 minutes. Furthermore, 
the graph showed that the amount of complexes SR φ1–HA 
increased over time (Figure 4A). Based on this result, we 
considered overnight incubation to be the optimal time 
interval for the complex synthesis.
The interaction between HA and SR φ1 was studied also 
through the zeta potential analysis, in which SR φ1 was 
negatively charged (-11.28±1.16) while HA was positively 
charged (2.9±0.9 mV). Therefore, the SR φ1 and HA complex 
showed a positive zeta potential of 0.9±1.60 mV (Figure 4B).
In addition, the stability of the SR φ1 and the HA–SR 
φ1 complex was assessed after the complex synthesis 
for about 2 months at 7 days intervals. Stability for long 
periods is essential for using phages in several biocontrol 
applications.58 The titer of the phage SR φ1 alone started to 
decrease already after 1 week; instead, when the phage was 
complexed with HA, its titer was stable for up to 6 weeks 
without any variation at the different time points analyzed 
(Figure 4C).
The analysis of the HA–SR φ1 complex stability at dif-
ferent pH values (ranging from 2 to 10) assessed the strong 
stability of the complex, compared to that of SR φ1 alone 
(Figure 4D). Further characterization of the complex was 
carried out by DLS analysis. During this test, no rapid aggre-
gation phenomenon was observed. As shown in Figure 4E, 
the diameter of HA was 300 nm while only diameter of SR 
φ1 was smaller (about 200 nm) than the HA. When HA and 
SR φ1 were complexed, the estimated hydrodynamic diam-
eter was about 400 nm, thereby confirming the interaction 
between these two elements as reported by Wang at al.59
XPD analysis showed that HA nanocrystals60 have a hex-
agonal crystalline structure (structure parameters are reported 
in Table S2). XPD patterns were further studied by using a 
whole-profile Rietveld-based fitting program49 as shown in 
Figure S4. The Rietveld analysis allowed us to determine cell 
parameters and crystalline domain size along the [002] and 
[110] crystallographic directions (summarized in Table S3). 
This analysis also showed the structural variation of the HA 
crystalline domain size with or without SR φ1 (Figure 5, 
black and red dots, respectively). When the HA percentage 
was increased, the samples without SR φ1 did not show any 
change in the crystalline domain size along [002] and [110] 
directions. Instead, when the HA amount was increased, in 
the case of the complex (HA–SR φ1), the crystalline domain 
size decreased (Figure 5).
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cytotoxicity trials
To evaluate the cytotoxic effect of SR φ1, HA, and the 
complex HA–SR φ1, a cell viability test was carried out 
by evaluating the reduction of MTT to formazan in human 
hepatocellular carcinoma HepG2 cells. The results showed 
that none of the treatments affected the cell vitality up to 
72 hours (Figure S5A).
Moreover, the amount of the extracellular enzyme 
LDH, a cell death indicator,61 was assessed under the same 
experimental conditions described above. Again, based on 
the amount of LHD produced, we concluded that none of the 
treatments produced cytotoxic effects (Figure S5B).
Internalization of fluorescent complex
As Salmonella spp. is an intracellular pathogen, the capac-
ity of the complex to penetrate HepG2 eukaryotic cells was 
evaluated by laser scanning confocal microscopy analysis. 
Figure 6 evidences the cell uptake of the complex. In par-
ticular, the complex HA–SR φ1 (HA colored in green) was 
internalized into the cytoplasm of the HepG2 cells after 
24 hours of treatment. Nuclei were counterstained with 
DAPI dye (blue). No fluorescent signal was detected in the 
control cells.
Intracellular killing activity
Once the ability of the complex to penetrate host cells was 
determined, the intracellular killing activity was gauged in 
two different experimental conditions: the HA–SR φ1 com-
plex was administered at 1 hour postinfection or together 
with Salmonella bacteria. The results showed that 1 hour 
postinfection, only HA–SR φ1 showed lytic activity against 
bacteria, reducing the bacterial load significantly (Figure 7A) 
while the effect of phages alone was minimal. In the second 
experiment, in which all the treatments were carried out 
simultaneously with the bacteria infection, both SR φ1 and 
HA–SR φ1 showed comparable lytic activity (Figure 7B). 
The data reported in Figure 7A evidenced that 1 hour after 
the infection with S. Rissen, the presence of biomimetic HA 
favored the uptake of phages into the HepG2 cells, allowing 
phages to kill also the intracellular bacteria.
Furthermore, Figure 7B showed that the biomimetic HA 
nanocrystals did not compromise the lytic activity of the 
??? ?????????????????????????? ????????
??? ???????????????
??????????????????????????????????????????????
?????????????????????????????
???? ?????????????????? ???????????
???? ??????? ??????????? ????????????????????????????????????
???????????????????????
????????????????????????????????????????
??? ?????????????????????
?????????? ??????????????
???????????? ?????????? ???????????? ???????????? ???????????? ?????????????φ? ????????????????????????????????????????????????????????????
??????????? ???????????? φ? ??????????
Figure 3 assignment of sr φ1 to the Podoviridae family.
Notes: The phylogenetic tree shows a strong DNa identity between sr φ1 and five members of the Podovoridae (three salmonella and two entero phages). The tree is based 
on the alignment of 39 phage genomes. The bar indicates branch length scale.
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???????????? ?
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??????φ?
???????
?????????????
??????????????
????????????
??? ??? ??? ????????????????????????? ? ?? ?? ?? ??
?????φ???????φ?
? ? ? ? ? ?????????
??????????????
???????
??????
?? ?????????
??????φ????φ?
??? ???? ? ???
??????????????
???????
??????
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??????φ????φ?
? ?
? ?
? ?????φ???????φ?
Figure 4 (A) The absorption of sr φ1 on ha after different times (30, 90, 180, 300 minutes and overnight) of incubation. each value is the mean ± sD of three independent 
experiments with three replicates each. (B) Zeta potential analysis of sr φ1, ha–sr φ1, and ha. (C) The half-life of the sr φ1 and the complex ha–sr φ1. each value is the 
mean ± sD of three independent experiments with three replicates each. (D) effects of ph on the stability of sr φ1 and ha–sr φ1. ***P,0.001. each value is the mean ± sD 
of three independent experiments with three replicates each. statistical analysis was performed with student’s t-test. (E) Dls analysis of the sr φ1, ha–sr φ1, and ha.
Abbreviations: Dls, dynamic light scattering; ha, hydroxyapatite; ND, not detectable; PFU, plaque forming unit.
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phages, when the complex was applied concurrently with 
the bacteria. The trend observed in HepG2 cells was also 
observed for murine macrophage cell line J774A.1 (data 
not shown).
Bacterial reduction assay on chicken 
minced meat
The efficacy of the complex HA–SR φ1 to reduce Salmonella 
contamination was investigated in chicken minced meat 
which is considered one of the meat categories intended to 
be cooked before consumption (together with mechanically 
separated meat and meat preparations) with the highest level 
of noncompliance, as reported by European Food Safety 
Authority (EFSA).62 S. Rissen colonies, in the sample treated 
with SR φ1, were reduced by 0.3 log CFU/g, while the sample 
treated with only HA was contaminated very similar to that 
of the positive control (5.5 log CFU/g). Instead, in the case 
of treatments with HA–SR φ1, the bacterial load of S. Rissen 
was reduced by 3 log CFU/g (Figure 8).
Discussion
Different material nanoparticles such as carbon, silica, metal 
oxide, graphene, and HA have been used in several studies 
to stabilize, protect, deliver, or enhance some biological 
properties of molecules.14–16,30,44
The characteristics of HA used in this study (such as 
composition, structure, size, and morphology) and the results 
obtained allow us to confirm that this mineral, due to its fea-
tures, was able to chemically interact not only with molecules 
but also with biological structures like bacteriophages. Its low 
degree of crystallinity and the presence of carbonate ions in 
the crystal structure are other important characteristics that 
make HA extremely reactive in biological systems, and par-
ticularly suitable to interact and transport the bacteriophages, 
as reported in this study.
The bacteriophage SR φ1 – isolated in this study – showed 
an efficient bacteriolytic activity against S. Livingstone, 
S. Infantis, S. Potsdam, S. Thompson, S. Mbandaka, 
S. Winston, S. Montevideo, S. Virchow, S. Ohio, S. 
Jerusalem, S. Inganda, S. Wil, S. Typhimurium, and S. 
Enteritidis as shown in Table 1. These results evidenced 
that it could be used as an antimicrobial agent against the 
strains of Salmonella spp. selected for this study. Further 
investigations are needed to evaluate whether the phage 
SR φ1 could show antimicrobial activity against other 
Salmonella strains and serovars.
Based on these results, we evaluated whether the use of 
HA could improve some properties of the bacteriophage. 
First, we used the mineral HA, which did not affect the cell 
viability and was not toxic for human cells (Figure S5).
??? ?????????????? ? ?? ?? ??????????????
????????
?? ???
??? ???????? ? ?? ?? ??????????????
????????
?? ?????????φ? ??
Figure 5 XPD analysis.
Note: apparent size along the: (A) [002] and (B) [110] crystallographic directions vs the ha percentage for the complex (ha–sr φ1) (black dots) and for ha alone (red dots).
Abbreviations: app, apparent; ha, hydroxyapatite; XPD, X-ray powder diffraction.
??????? ????
?????
Figure 6 confocal microscopy analysis.
Notes: control cells or cells treated with the complex at 24 hours. scale bars, 20 µm.
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The complex HA–SR φ1 showed enhanced lytic activ-
ity against S. Rissen than SR φ1 alone, thus indicating that 
the interaction with HA increased the antibacterial activity 
of the bacteriophage. Furthermore, the mineral contributed 
to stabilize the phage activity over time and at different pH 
values, making the complex suitable for long-term treat-
ment and effective for controlling infection in harsh niches, 
showing acid pH (such as stomach, urinary tract, etc), or 
in different physiological environments of healthy tissues 
(including blood).
The interaction of HA with phage is a good strategy to 
overcome the problem related to the reduction of bacterio-
phage viability in acidic conditions.12
The zeta potential analysis and DLS measurements 
demonstrated the interaction of the phage with HA. In fact, 
Figure 4B showed the behavior of the zeta potential of SR 
φ1 and HA alone and when they were complexed. In the 
latter case, neutralization of the negative surface charges of 
SR φ1 was observable. Because the charges of two elements 
are reversed, neutralization of the surface charges could be 
principally due to electrostatic interactions. Furthermore, the 
results of the DLS analysis allow us to hypothesize that when 
the two elements are complexed, the HA acts as a scaffold 
for the phages.
These results are also supported by Wang et al.59 Indeed, 
they demonstrated the ability of the bacteriophages to bind 
calcium ions, or non-stoichiometric HAs with positive 
zeta potential.59 The HA used in this study, just like the 
ones mentioned above, has a positive zeta potential, a non-
stoichiometric Ca/P ratio; all these characteristics induce the 
interaction of the HA with proteins and carboxyl groups of 
the phage capsid by the development of an electrostatic bond.
Some studies have shown the capacity of HA to permeate 
the cell membrane through the energy-dependent process 
of clathrin-mediated endocytosis63 or phagocytosis64 but 
have, also, highlighted that the permeabilization process is 
influenced by the equilibrium of multiple features such as 
dimension, charge, shape, and surface area.24,64–66
It has been reported that the bacteriophages are also able 
to bypass the cell membrane.67
?????????
???
??????
???????????????????????? ?????????
?????????????????????
????????????? ??????????????φ? ??????????????φ????
?
?????????
??????
??????
???????????????????????? ?????????
?????????????????????
????????????? ??????????????φ? ?????????????????φ?
?
Figure 7 Intracellular killing activity.
Notes: (A) First experiment. (B) second experiment. Positive control is represented by Salmonella rissen infected cells. ***P,0.001. each value is the mean ± sD of three 
independent experiments with three replicates each. statistical analysis was performed with student’s t-test.
Abbreviation: cFU, colony forming unit.
Figure 8 Bacterial reduction assay on chicken meat.
Notes: The samples of the meat were infected with Samonella rissen (103 cFU/ml) 
and were treated with sr φ1 (107 PFU/ml), ha–sr φ1 (100 mg/ml plus 107 PFU/ml), 
and ha (100 mg/ml). Positive control was represented by S. rissen infected meat. 
**P,0.01, ***P,0.001. each value is the mean ± sD of three independent experiments 
with three replicates each. statistical analysis was performed with student’s t-test.
Abbreviations: cFU, colony forming unit; ha, hydroxyapatite; PFU, plaque 
forming unit.
????????
??????????????????
?????????
?? ?? ???? ??????
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??? ??? ???
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Based on these evidences, we tested the capacity of the 
complex, and in particular the contribution of the mineral 
HA to penetrate into the eukaryotic cells. The results dem-
onstrated that, in the same infection condition, the presence 
of the mineral increases the number of phages that are able 
to penetrate into cells more efficiently and consequently 
kill intracellular bacteria.36 This mineral could be a good 
candidate in the use of phage therapy against obligate or 
facultative intracellular bacteria like Mycobacterium spp., 
Chlamydia spp., Rickettsia spp. or Salmonella spp., Listeria 
spp., and Brucella spp.68
In addition, another experiment was carried out on HepG2 
cells or J774A.1 cells not infected with bacteria. The results 
confirmed the ability of the HA to enter into eukaryotic 
cells and the capacity of bacteriophage to bypass the cell 
membrane (both reported in literature) and, at the same 
time, highlighted the role of HA in increasing the number of 
phages that pass through the cell membrane (data not shown) 
although there was no infection.
The last test, carried out to evaluate the efficacy of the 
complex to control bacterial infection in a food matrix such 
as chicken minced meat and for long time, showed the abil-
ity of the complex to reduce bacterial load also in the case 
of food contamination.
Conclusion
The main drawback in using phages are their lack of stability 
over time and their low activity against intracellular infec-
tions due to their low efficiency in penetrating eukaryotic 
cells. In addition, phages do not tolerate the low pH pres-
ent in the stomach and when used in food processing their 
activity can be compromised. In this study, these problems 
were successfully addressed by complexing phages with 
HA (nontoxic mineral for humans). This complex is stable, 
allows phages to enter eukaryotic cells more efficiently 
than phages alone, and, at the same time, the complexed 
phages were stable at very low pH. These results evidence 
the important contribution of HA making it a promising 
approach to overcome problems which could emerge when 
biological entities are used.
One of the most important problems in phage therapy 
is the application of phages as biocontrol agents against 
contamination in food.69 This drawback has been addressed, 
and it has been resolved by carrying out a test on infected 
meat. The results showed how HA enhances the lytic activ-
ity of phage to control bacterial meat infection. Strikingly, 
the complex is able to control Salmonella infection in food.
Furthermore, the approach proposed here (use of biomi-
metic HA nanocrystals as a carrier for bacteriophages) can 
be extended to different fields of interest such as biomedical, 
agricultural, and other commercial applications.
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